Consumers in the U.S. are increasingly finding it harder to trust the brands they do business with. This is why Newsweek is ...

Truist downgraded Sabra Health Care (SBRA) to Hold from Buy with a price target of $17, down from $18.Stay Ahead of the Market:Discover ...

Truist analyst Michael Lewis downgraded Sabra Health Care (SBRA) to Hold from Buy with a price target of $17, down from $18. The firm cites ...

JMP Securities has recently raised Sabra Health Care REIT Inc (SBRA) stock to Mkt Outperform rating, as announced on January 7, 2025, according to Finviz. Earlier, on December 5, 2024, Mizuho had ...

Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. The business had revenue of $178.00 million during the quarter, compared to the consensus estimate of $177.19 ...

Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same period last year, the business posted $0.34 earnings per share.

Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is ...

Sabra Health Care REIT (NYSE:WELL), Inc. (NASDAQ:SBRA), a real estate investment trust specializing in healthcare properties, is navigating a complex landscape of recovery and growth opportunities.

Sabra Health Care REIT (NYSE:WELL), Inc. (NASDAQ:SBRA), a real estate investment trust specializing in healthcare properties, is navigating a complex landscape of recovery and growth opportunities. As ...

As of December 23, 2024, the average one-year price target for Sabra Health Care REIT is $20.21/share. The forecasts range from a low of $18.18 to a high of $22.05.